IWcee16 main topic this year will be:
“Coping with Uncertainty in Complex Socio-Economic Systems”
Economies are sophisticated social systems characterized by pervasive uncertainty, which makes agents’ behaviours and systemic outcomes difficult to predict. The study of such systems thus requires new datasets and more reliable statistical techniques. This is a necessary requirement for enabling policymakers to assess and regulate economic performance vis-à-vis uncertainty. IWcee16 aims to raise a rigorous scientific debate on the many interconnections between uncertainty and socio-economic performance, by focusing on the tools offered by modern quantitative socio-economic science.
Papers on the following topics are highly welcome:
Measuring and communicating uncertainty; Uncertainty propagation in relational systems; Sensitivity analysis and robustness methods; Network dynamics and resilience; Agent-based and game-theory modelling of uncertain environments; Risk analysis; Chaotic socio-economic systems; Causal inference and identification under uncertainty; Time series analysis and forecasting techniques, Big Data analysis
The deadline for abstract submission to email@example.com is: April 15, 2016.
If you have any query or curiosity, please contact: firstname.lastname@example.org
We invite you to attend the Molecular Diagnostics Summit, which takes place July 6 - 8, 2016 inBoston, MA. The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below:
2nd Cancer Markers & Liquid Biopsies:
The role of cancer markers is significant towards the diagnosis, prognosis, and surveillance of a patient. Understanding markers and characterizing circulating elements with the latest technologies aid our progress toward the future of better personalized cancer care. Leaders in industry and academia will discuss platforms for isolating and studying CTCs. Technologies such as next generation sequencing and digital PCR are gaining momentum in these research areas. This meeting will also discuss biomarker sensitivity, stability, validation, and how we can use markers to follow up with patients and improve the quality of life.
There is a huge drive in Precision Medicine as it integrates research and clinical practice to build a knowledge base that can better guide individualized patient care. At a crucial time, where there are efforts to scale up population-based genome sequencing and integrate it with clinical data, this meeting will discuss the progress towards the implementation of precision medicine. This conference will discuss the future of healthcare, strategies and technologies for successful implementation, precision medicine beyond oncology, integrating and interpreting personal genomics, big data, bioinformatics, and overcoming challenges in the commercialization of precision medicine.
Digital PCR & qPCR:
There has been a push to find a faster and a more efficient way to optimize the quantification of nucleic acids. In the past, quantitative polymerase chain reaction (qPCR) has been the best way to measure the relative amplification of PCR in real time. In more recent years, digital PCR has become a newer method of PCR quantification that can result in absolute quantification, increased sensitivity in samples, more controllable precision, and multiple partitions of the same sample. This meeting will discuss the newest developments in digital PCR and qPCR in relation to how PCR can be used the molecular diagnostics field.